Analyst firms · Jefferies · ICLR
Jefferies ICLR price target and rating history
ICON plc (ICLR) · Health Care
Jefferies rates ICON plc (ICLR) Buy with a $135 price target, as of its latest action on Feb 23, 2026. It has published 3 rating actions on ICLR since September 2021, including 1 upgrade and 1 downgrade. Across 9 firms with a ICLR price target in the last 12 months, the median target is $135. Jefferies's target matches it.
- Current rating
- Buy
- Price target
- $135
- Median target, all firms
- $135
- Actions on ICLR
- 3
Jefferies price target on ICLR
Every Jefferies rating on ICLR
- Feb 23, 2026
- Sep 9, 2025
- Sep 14, 2021
How other firms rate ICLR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BofA Securities | Neutral | $185 | Oct 9, 2026 |
| UBS | Neutral | $195 | Sep 30, 2026 |
| Truist Securities | Buy | $207 | Jun 30, 2026 |
| RBC Capital Markets | Outperform | $185 | Jun 25, 2026 |
| BMO Capital Markets | Outperform | $130 | Mar 26, 2026 |
| Jefferies | Buy | $135 | Feb 23, 2026 |
| TD Cowen | Buy | $120 | Feb 18, 2026 |
| Rothschild & Co Redburn | Neutral | $100 | Feb 17, 2026 |
| Leerink Partners | Market Perform | $105 | Feb 12, 2026 |
Questions about Jefferies and ICLR
- What is Jefferies's price target for ICLR?
- Jefferies's latest stated price target for ICON plc (ICLR) is $135, from its action on Feb 23, 2026.
- What is Jefferies's rating on ICLR?
- Jefferies rates ICLR Buy, a bullish rating, as of Feb 23, 2026.
- When did Jefferies last change its view on ICLR?
- On Feb 23, 2026, Jefferies upgrades to Buy from Hold, price target $135.
- How does Jefferies's ICLR target compare with other analysts?
- Across 9 firms with a ICLR price target in the last 12 months, the median target is $135. Jefferies's target matches it.
More ICLR rating histories
- BofA Securities4
- Truist Securities3
- RBC Capital Markets3
- TD Cowen3
- Rothschild & Co Redburn3
- Citigroup4
- Barclays6
- Credit Suisse3
All Jefferies ratingsICLR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.